Stick With Dexcom Inc (DXCM). The Bull Are Alive And Well

Currently, there are 390.70M common shares owned by the public and among those 386.62M shares have been available to trade.

The company’s stock has a 5-day price change of 14.07% and -12.56% over the past three months. DXCM shares are trading -10.98% year to date (YTD), with the 12-month market performance down to -49.15% lower. It has a 12-month low price of $57.52 and touched a high of $139.24 over the same period. DXCM has an average intraday trading volume of 4.26 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.43%, -10.17%, and -11.92% respectively.

Institutional ownership of Dexcom Inc (NASDAQ: DXCM) shares accounts for 92.54% of the company’s 390.70M shares outstanding.

It has a market capitalization of $27.15B and a beta (3y monthly) value of 1.43. The stock’s trailing 12-month PE ratio is 48.60, while the earnings-per-share (ttm) stands at $1.42. The company has a PEG of 2.14 and a Quick Ratio of 1.28 with the debt-to-equity ratio at 1.23. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.83% over the week and 4.92% over the month.

Earnings per share for the fiscal year are expected to increase by 23.37%, and 22.50% over the next financial year. EPS should shrink at an annualized rate of 22.69% over the next five years, compared to 39.06% over the past 5-year period.

Looking at the support for the DXCM, a number of firms have released research notes about the stock. Mizuho stated their Outperform rating for the stock in a research note on April 10, 2025, with the firm’s price target at $85. Redburn Atlantic coverage for the Dexcom Inc (DXCM) stock in a research note released on February 03, 2025 offered a Buy rating with a price target of $115. Robert W. Baird was of a view on January 16, 2025 that the stock is Outperform, while Robert W. Baird gave the stock Neutral rating on July 26, 2024, issuing a price target of $161- $80. JP Morgan on their part issued Neutral rating on July 26, 2024.

Most Popular

Related Posts